Latest News From Lumira Ventures

BAROnova Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the TransPyloric Shuttle® (TPS®) Device Intended for the Treatment of Obesity

Ahmed Khan Portfolio News

SAN CARLOS, Calif., /PRNewswire/ — BAROnova, Inc., announced today that it has submitted a Pre-Market Approval (PMA) application for the TransPyloric Shuttle device intended for the treatment of obesity to the Food and Drug Administration (FDA). Obesity is a worldwide epidemic with …

Antiva Biosciences Closes $15 Million Series C-1 Financing

Ahmed Khan Portfolio News

SOUTH SAN FRANCISCO, California, /PRNewswire/ — Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by human papilloma virus (HPV) infection, has raised $15 million in Series C-1 financing led by Hillhouse Capital Management. Sirona …

Lumira Ventures. Rebranded.

Ahmed Khan Main Page, Lumira News

Today, Lumira Ventures is excited to debut its new website at www.lumiraventures.com, new branding and change of name from Lumira Capital to Lumira Ventures. Over the past 30 years, Lumira has been at the forefront of the healthcare investment industry. …